ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9T9738
Home | Market Reports | Health| Health Conditions
Global Chronic Kidney Disease Mineral and Bone Disorders CKD MBD Market Insights and Forecast to 2028
BUY CHAPTERS

Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Research Report 2025

Code: QYRE-Auto-9T9738
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Akebia
Astellas
Takeda
Vifor
AbbVie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi Sankyo
SHIELD
Spectrum
OPKO
Ardelyx Inc
Sanofi Genzyme
Amgen Inc

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market

The global market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a term that describes the systemic disorder that affects the bones, heart, and blood vessels of people with chronic kidney disease (CKD). CKD-MBD is caused by the abnormal function of the kidneys, which cannot filter blood and regulate hormones properly. This leads to imbalances in calcium, phosphorus, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and vitamin D metabolism. These imbalances can result in bone abnormalities, such as low or high bone turnover, mineralization defects, fractures, and growth impairment. They can also cause extraskeletal calcification, which is the deposition of calcium and phosphorus in the blood vessels and other tissues, increasing the risk of cardiovascular complications and mortality.
The future market trends of CKD-MBD treatment are influenced by several factors, such as the increasing prevalence of CKD, the aging population, the rising awareness and diagnosis of CKD-MBD, the development of novel and effective therapies, and the unmet medical needs of patients with CKD-MBD. Some of the current and emerging therapies for CKD-MBD include medications and supplements, such as phosphate binders, vitamin D analogs, calcimimetics, iron, and erythropoiesis-stimulating agents (ESAs); dialysis, which removes excess fluid and waste products from the blood; surgery, such as parathyroidectomy, which removes the overactive parathyroid glands; diet, which restricts the intake of phosphorus, calcium, and protein; and others, such as bone-modifying agents, calcification inhibitors, and FGF23 inhibitors. The market for CKD-MBD treatment is expected to grow due to the high demand for these therapies, the innovation and advancement in technology, the increasing investment and research in this field, and the expansion of the target population.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Report

Report Metric Details
Report Name Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
Segment by Type
  • Control Hyperphosphatemia
  • Maintain Blood Calcium Levels
  • Control PTH Level
  • Correct Acidosis
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol, Japan Tobacco Company, Daiichi-Sankyo, Shield, Spectrum, OPKO, Ardelyx, Sanofi Genzyme, Amgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report?

Ans: The main players in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market are Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol, Japan Tobacco Company, Daiichi-Sankyo, Shield, Spectrum, OPKO, Ardelyx, Sanofi Genzyme, Amgen

What are the Application segmentation covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report?

Ans: The Applications covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Others

What are the Type segmentation covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report?

Ans: The Types covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report are Control Hyperphosphatemia, Maintain Blood Calcium Levels, Control PTH Level, Correct Acidosis, Others

1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Overview
1.1 Product Definition
1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type
1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Control Hyperphosphatemia
1.2.3 Maintain Blood Calcium Levels
1.2.4 Control PTH Level
1.2.5 Correct Acidosis
1.2.6 Others
1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application
1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.3.6 Others
1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2031
1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2031
1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competition by Manufacturers
2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application
2.7 Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Date of Enter into This Industry
2.8 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation and Trends
2.8.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue
2.8.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Scenario by Region
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2020-2031
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2020-2025
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2026-2031
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2020-2031
3.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2020-2025
3.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2026-2031
3.4 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.4.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2031)
3.4.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.5.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2031)
3.5.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2031)
3.6.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.7.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2031)
3.7.3 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2031)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2026-2031)
4.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2031)
4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2020-2031)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2020-2025)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2026-2031)
4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2031)
4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2031)
5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2026-2031)
5.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2031)
5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2020-2031)
5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2020-2025)
5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2026-2031)
5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2020-2031)
5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Akebia
6.1.1 Akebia Company Information
6.1.2 Akebia Description and Business Overview
6.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.1.5 Akebia Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Company Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Vifor
6.4.1 Vifor Company Information
6.4.2 Vifor Description and Business Overview
6.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.4.5 Vifor Recent Developments/Updates
6.5 Abbvie
6.5.1 Abbvie Company Information
6.5.2 Abbvie Description and Business Overview
6.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.5.5 Abbvie Recent Developments/Updates
6.6 Fresenius
6.6.1 Fresenius Company Information
6.6.2 Fresenius Description and Business Overview
6.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.6.5 Fresenius Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Novadiol
6.8.1 Novadiol Company Information
6.8.2 Novadiol Description and Business Overview
6.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.8.5 Novadiol Recent Developments/Updates
6.9 Japan Tobacco Company
6.9.1 Japan Tobacco Company Company Information
6.9.2 Japan Tobacco Company Description and Business Overview
6.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.9.5 Japan Tobacco Company Recent Developments/Updates
6.10 Daiichi-Sankyo
6.10.1 Daiichi-Sankyo Company Information
6.10.2 Daiichi-Sankyo Description and Business Overview
6.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.10.5 Daiichi-Sankyo Recent Developments/Updates
6.11 Shield
6.11.1 Shield Company Information
6.11.2 Shield Description and Business Overview
6.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.11.5 Shield Recent Developments/Updates
6.12 Spectrum
6.12.1 Spectrum Company Information
6.12.2 Spectrum Description and Business Overview
6.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.12.5 Spectrum Recent Developments/Updates
6.13 OPKO
6.13.1 OPKO Company Information
6.13.2 OPKO Description and Business Overview
6.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.13.5 OPKO Recent Developments/Updates
6.14 Ardelyx
6.14.1 Ardelyx Company Information
6.14.2 Ardelyx Description and Business Overview
6.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.14.5 Ardelyx Recent Developments/Updates
6.15 Sanofi Genzyme
6.15.1 Sanofi Genzyme Company Information
6.15.2 Sanofi Genzyme Description and Business Overview
6.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.15.5 Sanofi Genzyme Recent Developments/Updates
6.16 Amgen
6.16.1 Amgen Company Information
6.16.2 Amgen Description and Business Overview
6.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.16.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Chain Analysis
7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process Analysis
7.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Marketing
7.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels
7.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
7.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer Analysis
8 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Dynamics
8.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
8.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
8.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Akebia
Astellas
Takeda
Vifor
AbbVie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi Sankyo
SHIELD
Spectrum
OPKO
Ardelyx Inc
Sanofi Genzyme
Amgen Inc
List of Tables
 Table 1. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application
 Table 12. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025) & (MT)
 Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2020-2025)
 Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2026-2031) & (MT)
 Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2026-2031)
 Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2020-2025)
 Table 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2026-2031)
 Table 25. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
 Table 27. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2026-2031) & (MT)
 Table 28. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
 Table 32. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2026-2031) & (MT)
 Table 33. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Type (2020-2025)
 Table 51. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Type (2026-2031)
 Table 52. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
 Table 53. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2026-2031)
 Table 54. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2025)
 Table 57. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2026-2031)
 Table 58. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Application (2020-2025)
 Table 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Application (2026-2031)
 Table 62. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
 Table 63. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2026-2031)
 Table 64. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2020-2025)
 Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2026-2031)
 Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2026-2031)
 Table 70. Akebia Company Information
 Table 71. Akebia Description and Business Overview
 Table 72. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 74. Akebia Recent Developments/Updates
 Table 75. Astellas Company Information
 Table 76. Astellas Description and Business Overview
 Table 77. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 79. Astellas Recent Developments/Updates
 Table 80. Takeda Company Information
 Table 81. Takeda Description and Business Overview
 Table 82. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 84. Takeda Recent Developments/Updates
 Table 85. Vifor Company Information
 Table 86. Vifor Description and Business Overview
 Table 87. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 89. Vifor Recent Developments/Updates
 Table 90. Abbvie Company Information
 Table 91. Abbvie Description and Business Overview
 Table 92. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 94. Abbvie Recent Developments/Updates
 Table 95. Fresenius Company Information
 Table 96. Fresenius Description and Business Overview
 Table 97. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 99. Fresenius Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. Novadiol Company Information
 Table 106. Novadiol Description and Business Overview
 Table 107. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 109. Novadiol Recent Developments/Updates
 Table 110. Japan Tobacco Company Company Information
 Table 111. Japan Tobacco Company Description and Business Overview
 Table 112. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 114. Japan Tobacco Company Recent Developments/Updates
 Table 115. Daiichi-Sankyo Company Information
 Table 116. Daiichi-Sankyo Description and Business Overview
 Table 117. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 119. Daiichi-Sankyo Recent Developments/Updates
 Table 120. Shield Company Information
 Table 121. Shield Description and Business Overview
 Table 122. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 124. Shield Recent Developments/Updates
 Table 125. Spectrum Company Information
 Table 126. Spectrum Description and Business Overview
 Table 127. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 129. Spectrum Recent Developments/Updates
 Table 130. OPKO Company Information
 Table 131. OPKO Description and Business Overview
 Table 132. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 133. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 134. OPKO Recent Developments/Updates
 Table 135. Ardelyx Company Information
 Table 136. Ardelyx Description and Business Overview
 Table 137. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 138. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 139. Ardelyx Recent Developments/Updates
 Table 140. Sanofi Genzyme Company Information
 Table 141. Sanofi Genzyme Description and Business Overview
 Table 142. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 143. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 144. Sanofi Genzyme Recent Developments/Updates
 Table 145. Amgen Company Information
 Table 146. Amgen Description and Business Overview
 Table 147. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 148. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
 Table 149. Amgen Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
 Table 153. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List
 Table 154. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
 Table 155. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
 Table 156. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
 Table 157. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
 Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type: 2024 & 2031
 Figure 4. Control Hyperphosphatemia Product Picture
 Figure 5. Maintain Blood Calcium Levels Product Picture
 Figure 6. Control PTH Level Product Picture
 Figure 7. Correct Acidosis Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Drug Stores
 Figure 15. Others
 Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2020-2031) & (MT)
 Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (USD/Kg) & (2020-2031)
 Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
 Figure 21. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers in 2024
 Figure 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players: Market Share by Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2024
 Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2031)
 Figure 27. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2031)
 Figure 31. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2020-2031)
 Figure 39. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type (2020-2031)
 Figure 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application (2020-2031)
 Figure 64. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2020-2031)
 Figure 65. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Renal Therapeutic Market Research Report 2025
Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Medication Market Research Report 2024
Global End Stage Kidney Disease Market Research Report 2024
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Global End Stage Renal Disease Market Research Report 2024
Global Renal Diseases Drug Market Insights Forecast to 2030
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024
Global Bone Mineral Testing Market Research Report 2024
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global CKD and ESRD Treatment Market Research Report 2025
Global End Stage Renal Disease ESRD Device Market Research Report 2024
Global Hemodialysis Service Market Research Report 2025
Global Kidney Supplement Market Research Report 2024
Global Kidney Nutrition Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions